Z Gastroenterol 2004; 42(9): 988-993
DOI: 10.1055/s-2004-813509
Leitlinien

© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York

Klinische Diagnostik

Clinical DiagnosisU. Knebel1 , H.-J Brambs2 , J. F. Riemann1
  • 1Klinikum der Stadt Ludwigshafen gGmbH, Medizinische Klinik C, Ludwigshafen
  • 2Universitätsklinikum Ulm, Abt. Diagnostische Radiologie, Ulm
Further Information

Publication History

Publication Date:
29 September 2004 (online)

Klinik

Empfehlung

Vor einer weiterführenden Diagnostik sind eine anamnestische Erhebung und eine klinische Untersuchung obligat (C). Bei einer Colitis ulcerosa finden sich anamnestisch häufig eines oder mehrere der folgenden Symptome: blutige Diarrhöen, erhöhte Stuhlfrequenz, vermehrter Stuhldrang, nächtliche Defäkation, Tenesmen, Gefühl der inkompletten Stuhlentleerung, Fieber (B).

Erläuterung

Zunächst soll die Relevanz einer ausführlichen Anamneseerhebung sowie körperlichen Untersuchung vor jeglicher weiterführender Diagnostik unterstrichen werden. Hinsichtlich der anamnestisch erhebbaren Symptome finden sich relativ wenige Studien, die die Häufigkeit einzelner Symptome bei der Colitis ulcerosa untersucht haben. Blutige Diarrhöen stellen in den meisten Fällen das Leitsymptom der Colitis ulcerosa dar. Die Reihenfolge der weiteren Symptome entspricht nicht ihrer Häufigkeit, da hierzu kaum valide Daten existieren [1] [2] [3] [4]. Die Symptomatik lässt nicht sicher auf das zu erwartende Befallsmuster bzw. die Ausdehnung der Erkrankung schließen. Die Daten sind inhomogen, insgesamt scheint jedoch eine stärkere Ausprägung der Symptome mit einer erhöhten endoskopischen Aktivität zu korrelieren [5] [6] [7].

Literatur

  • 1 Rao S S, Holdsworth C D, Read N W. Symptoms and stool patterns in patients with ulcerative colitis.  Gut. 1988;  29 342-345 (IIb)
  • 2 Both H, Torp-Pedersen K, Kreiner S. et al . Clinical appearance at diagnosis of ulcerative colitis and Crohn’s disease in a regional patient group.  Scand J Gastroenterol. 1983;  18 987-991 (IIb)
  • 3 Drossman D A, Li Z, Leserman J. et al . Ulcerative colitis and Crohn’s disease health status scales for research and clinical practice.  J Clin Gastroenterol. 1992;  15 104-112 (IIb)
  • 4 Rath H C, Caesar I, Roth M. et al . Mangelzustände und Komplikationen bei chronisch entzündlichen Darmerkrankungen.  Med Klin. 1998;  93 6-10 (IIb)
  • 5 Powell-Tuck J, Day D W, Buckell N A. et al . Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.  Dig Dis Sci. 1982;  27 533-537 (IIb)
  • 6 Gomes P, du B oulay C, Smith C L. et al . Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.  Gut. 1986;  27 92-95 (IIb)
  • 7 Seo M, Okada M, Maeda K. et al . Correlation between endoscopic severity and the clinical activity index in ulcerative colitis.  Am J Gastroenterol. 1998;  93 2124-2129 (IIb)
  • 8 Vatay A, Bene L, Kovacs A. et al . Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.  Immunogenetics. 2003;  55 247-252 (IIb)
  • 9 Descos L, Andre F, Andre C. et al . Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis.  Digestion. 1983;  28 148-152 (IIb)
  • 10 Moran A, Jones A, Asquith P. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn’s colitis.  Scand J Gastroenterol. 1995;  30 356-360 (IIb)
  • 11 Bunn S K, Bisset W M, Main M J. et al . Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.  J Pediatr Gastroenterol Nutr. 2001;  32 171-177 (III)
  • 12 Tibble J A, Sigthorsson G, Bridger S. et al . Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.  Gastroenterology. 2000;  119 15-22 (IIa)
  • 13 Roseth A G, Schmidt P N, Fagerhol M K. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.  Scand J Gastroenterol. 1999;  34 50-54 (III)
  • 14 Kayazawa M, Saitoh O, Kojima K. et al . Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.  Am J Gastroenterol. 2002;  97 360-369 (IIb)
  • 15 Kane S V, Sandborn W J, Rufo P A. et al . Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.  Am J Gastroenterol. 2003;  98 1309-1314 (Ib)
  • 16 Carroccio A, Iacono G, Cottone M. et al . Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children.  Clin Chem. 2003;  49 861-867 (Ib)
  • 17 Sandborn W J, Loftus E V Jr, Colombel J F. et al . Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn’s disease.  Inflamm Bowel Dis. 2001;  7 192-201 (IIb)
  • 18 Joossens S, Reinisch W, Vermeire S. et al . The value of serologic markers in indeterminate colitis: a prospective follow-up study.  Gastroenterology. 2002;  122 1242-1247 (IIa)
  • 19 Dubinsky M C, Ofman J J, Urman M. et al . Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.  Am J Gastroenterol. 2001;  96 758-765 (IIb)
  • 20 O’Morain C, Tobin A, Leen E. et al . Criteria of case definition in Crohn’s disease and ulcerative colitis.  Scand J Gastroenterol Suppl. 1989;  170: 7 - 11; discussion 16 - 19 (IIb)
  • 21 Boom R, Sol C, Weel J. et al . Detection and quantitation of human cytomegalovirus DNA in faeces.  J Virol Methods. 2000;  84 1-14 (IIb)
  • 22 Cottone M, Pietrosi G, Martorana G. et al . Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis.  Am J Gastroenterol. 2001;  96 773-775 (III)
  • 23 Adani G L, Avital I, Ferraresso C. et al . CMV infection in severe refractory ulcerative and Crohn’s colitis.  Am J Gastroenterol. 2001;  96 3464-3465 (IV)
  • 24 Cooper H S, Raffensperger E C, Jonas L. et al . Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection.  Gastroenterology. 1977;  72 1253-1256 (III)
  • 25 Papadakis K A, Tung J K, Binder S W. et al . Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.  Am J Gastroenterol. 2001;  96 2137-2142 (III)
  • 26 Kaufman H S, Kahn A C, Iacobuzio-Donahue C. et al . Cytomegaloviral enterocolitis: clinical associations and outcome.  Dis Colon Rectum. 1999;  42 24-30 (IIb)
  • 27 Lee S D, Cohen R D. Endoscopy in inflammatory bowel disease.  Gastroenterol Clin North Am. 2002;  31 119-132 (IV)
  • 28 Rutgeerts P, Peeters M, Geboes K. et al . Infectious agents in inflammatory bowel disease.  Endoscopy. 1992;  24 565-567 (IV)
  • 29 Horing E, Gopfert D, Schroter G. et al . Frequency and spectrum of microorganisms isolated from biopsy specimens in chronic colitis.  Endoscopy. 1991;  23 325-327 (IIb)
  • 30 Caradonna L, Amati L, Magrone T. et al . Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.  J Endotoxin Res. 2000;  6 205-214 (IIb)
  • 31 D’Haens G, Geboes K, Peeters M. et al . Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.  Am J Gastroenterol. 1997;  92 1275-1279 (IIb)
  • 32 Hill M D, Davies G, McIntyre A S. et al . Proctitis with caecitis: an atypical presentation of ulcerative colitis.  Endoscopy. 2002;  34 664-666 (IV)
  • 33 Heuschen U A, Hinz U, Allemeyer E H. et al . Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.  Gastroenterology. 2001;  120 841-847 (IIb)
  • 34 Kleer C G, Appelman H D. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time.  Am J Surg Pathol. 1998;  22 983-989 (IIb)
  • 35 Geboes K, Ectors N, D’Haens G. et al . Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?.  Am J Gastroenterol. 1998;  93 201-206 (IIb)
  • 36 Pera A, Bellando P, Caldera D. et al . Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score.  Gastroenterology. 1987;  92 181-185 (IIb)
  • 37 Floren C H, Benoni C, Willen R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis.  Scand J Gastroenterol. 1987;  22 459-462 (IIb)
  • 38 Riley S A, Mani V, Goodman M J. et al . Microscopic activity in ulcerative colitis: what does it mean?.  Gut. 1991;  32 174-178 (IIb)
  • 39 Dejaco C, Oesterreicher C, Angelberger S. et al . Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis.  Endoscopy. 2003;  35 1004-1008 (IIb)
  • 40 Moum B, Ekbom A, Vatn M H. et al . Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time.  Am J Gastroenterol. 1999;  94 1564-1569 (IIb)
  • 41 Fernandez-Banares F, Salas A, Esteve M. et al . Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.  Am J Gastroenterol. 2003;  98 340-347 (IIb)
  • 42 Shah R J, Fenoglio-Preiser C, Bleau B L. et al . Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea.  Am J Gastroenterol. 2001;  96 1091-1095 (III)
  • 43 Yusoff I F, Ormonde D G, Hoffman N E. Routine colonic mucosal biopsy and ileoscopy increases diagnostic yield in patients undergoing colonoscopy for diarrhea.  J Gastroenterol Hepatol. 2002;  17 276-280 (III)
  • 44 Levine T S, Tzardi M, Mitchell S. et al . Diagnostic difficulty arising from rectal recovery in ulcerative colitis.  J Clin Pathol. 1996;  49 319-323 (III)
  • 45 Markowitz J, Kahn E, Grancher K. et al . Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis.  Am J Gastroenterol. 1993;  88 2034-2037 (III)
  • 46 Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making.  Am J Gastroenterol. 1991;  86 187-190 (IIb)
  • 47 Carbonnel F, Lavergne A, Lemann M. et al . Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.  Dig Dis Sci. 1994;  39 1550-1557 (III)
  • 48 Swan N C, Geoghegan J G, O’Donoghue D P. et al . Fulminant colitis in inflammatory bowel disease: detailed pathologic and clinical analysis.  Dis Colon Rectum. 1998;  41 1511-1515 (IIb)
  • 49 Meucci G, Bortoli A, Riccioli F A. et al . Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).  Eur J Gastroenterol Hepatol. 1999;  11 909-913 (IIb)
  • 50 Moum B, Ekbom A, Vatn M H. et al . Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.  Gut. 1997;  40 328-332 (IIb)
  • 51 Jaramillo E, Watanabe M, Befrits R. et al . Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy.  Gastrointest Endosc. 1996;  44 15-22 (IIb)
  • 52 Matsumoto T, Kuroki F, Mizuno M. et al . Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis.  Gastrointest Endosc. 1997;  46 400-405 (III)
  • 53 Tung S Y, Wu C S, Su M Y. Magnifying colonoscopy in differentiating neoplastic from nonneoplastic colorectal lesions.  Am J Gastroenterol. 2001;  96 2628-2632 (IIb)
  • 54 Kiesslich R, Fritsch J, Holtmann M. et al . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888 (Ib)
  • 55 Schwerk W BBK, Raith M. A prospective evaluation of high resolution sonography in the diagnosis of inflammatory bowel disease.  Eur J Gastroenterol Hepatol. 1992;  172-182 (IIb)
  • 56 Gumaste V, Sachar D B, Greenstein A J. Benign and malignant colorectal strictures in ulcerative colitis.  Gut. 1992;  33 938-941 (IIb)
  • 57 Oberhuber G, Puspok A, Oesterreicher C. et al . Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease.  Gastroenterology. 1997;  112 698-706 (IIb)
  • 58 Parente F, Cucino C, Bollani S. et al . Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.  Am J Gastroenterol. 2000;  95 705-711 (IIb)
  • 59 Hollerbach S, Geissler A, Schiegl H. et al . The accuracy of abdominal ultrasound in the assessment of bowel disorders.  Scand J Gastroenterol. 1998;  33 1201-1208 (IIb)
  • 60 Arienti V, Campieri M, Boriani L. et al . Management of severe ulcerative colitis with the help of high resolution ultrasonography.  Am J Gastroenterol. 1996;  91 2163-2169 (IIb)
  • 61 Parente F, Greco S, Molteni M. et al . Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel.  Aliment Pharmacol Ther. 2003;  18 1009-1016 (IIb)
  • 62 Haber H P, Busch A, Ziebach R. et al . Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides.  J Ultrasound Med. 2002;  21 375-382 (III)
  • 63 Bru C, Sans M, Defelitto M M. et al . Hydrocolonic sonography for evaluating inflammatory bowel disease.  AJR Am J Roentgenol. 2001;  177 99-105 (IIb)
  • 64 Limberg B. [Diagnosis of chronic inflammatory bowel disease by ultrasonography].  Z Gastroenterol. 1999;  37 495-508 (IV)
  • 65 Kalantzis N, Rouvella P, Tarazis S. et al . Doppler US of superior mesenteric artery in the assessment of ulcerative colitis. A prospective study.  Hepatogastroenterology. 2002;  49 168-171 (IIa)
  • 66 Maconi G, Imbesi V, Bianchi Porro G. Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease.  Scand J Gastroenterol. 1996;  31 590-593 (IIb)
  • 67 Sigirci A, Baysal T, Kutlu R. et al . Doppler sonography of the inferior and superior mesenteric arteries in ulcerative colitis.  J Clin Ultrasound. 2001;  29 130-139 (IIb)
  • 68 Ludwig D, Wiener S, Bruning A. et al . Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.  Gut. 1999;  45 546-552 (IIa)
  • 69 Higaki S, Nohara H, Saitoh Y. et al . Increased rectal wall thickness may predict relapse in ulcerative colitis: a pilot follow-up study by ultrasonographic colonoscopy.  Endoscopy. 2002;  34 212-219 (IIb)
  • 70 Gast P, Belaiche J. Rectal endosonography in inflammatory bowel disease: differential diagnosis and prediction of remission.  Endoscopy. 1999;  31 158-166 (III)
  • 71 Dagli U, Over H, Tezel A. et al . Transrectal ultrasound in the diagnosis and management of inflammatory bowel disease.  Endoscopy. 1999;  31 152-157 (III)
  • 72 Ajaj W, Pelster G, Treichel U. et al . Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology.  Gut. 2003;  52 1738-1743 (III)
  • 73 Sardanelli F, de Cicco E, Renzetti P. et al . Double-contrast magnetic resonance examination of ulcerative colitis.  Eur Radiol. 1999;  9 875-879 (IIa)
  • 74 Shoenut J P, Semelka R C, Magro C M. et al . Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease.  J Clin Gastroenterol. 1994;  19 31-35 (IIb)
  • 75 Madsen S M, Thomsen H S, Munkholm P. et al . Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99 mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery.  Scand J Gastroenterol. 2002;  37 307-316 (IIb)
  • 76 Albert J, Scheidt T, Basler B. et al . [Magnetic Resonance Imaging in diagnosis and follow-up of Crohn’s Disease - Is conventional enteroclysis still necessary?].  Z Gastroenterol. 2002;  40 789-794 (IIb)
  • 77 Rieber A, Nussle K, Reinshagen M. et al . MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease.  Abdom Imaging. 2002;  27 394-399 (IV)
  • 78 Hansmann H J, Hess T, Hahmann M. et al . [MRI in chronic inflammatory bowel disease].  Fortschr Röntgenstr. 2001;  173 4-11 (IV)
  • 79 Voderholzer W A, Ortner M, Rogalla P. et al . Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis.  Endoscopy. 2003;  35 1009-1014 (IIb)
  • 80 Fireman Z, Mahajna E, Broide E. et al . Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy.  Gut. 2003;  52 390-392 (IIb)
  • 81 Eliakim R, Fischer D, Suissa A. et al . Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn’s disease.  Eur J Gastroenterol Hepatol. 2003;  15 363-367 (IIb)
  • 82 Grahnquist L, Chapman S C, Hvidsten S. et al . Evaluation of 99 mTc-HMPAO leukocyte scintigraphy in the investigation of pediatric inflammatory bowel disease.  J Pediatr. 2003;  143 48-53 (IIb)

Prof. Dr. J. F. Riemann

Klinikum der Stadt Ludwigshafen gGmbH, Medizinische Klinik C

Bremerstr. 79

67073 Ludwigshafen

Phone: ++ 49/6 21/5 03 41 00

Fax: ++ 49/6 21/5 03 41 14

Email: riemannj@klilu.de